- call +1-201-465-4211
- email sales@marketsandresearch.biz
- Call +1-201-465-4211
- Email: sales@marketsandresearch.biz
The Dexchlorpheniramine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest study, due to COVID-19 pandemic, the global Dexchlorpheniramine market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Antiallergic Agent accounting for % of the Dexchlorpheniramine global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Patent segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Dexchlorpheniramine include LETI, Novartis, Hypera Pharma, Woodward, and Merck, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Dexchlorpheniramine market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Patent
Generic
Market segment by Application can be divided into
Antiallergic Agent
Histamine H₁-Receptor Antagonist
The key market players for global Dexchlorpheniramine market are listed below:
LETI
Novartis
Hypera Pharma
Woodward
Merck
Johnson and Johnson
Ethical Pharma
Gems Pharma
KPL Pharma
GlaxoSmithKline
Ying Yuan
Schering-Plough
Towa Yakuhin
Mantecorp FSA
Kalbe
Teva
Bayer
Mekophar
CFR Pharmaceuticals
Armoxindo Farma
Sawai Seiyaku
Pfizer
Instituto Sanitas
Caillon and Hamonet
Kobayashi Kako
Greater Pharma
Teuto Brasileiro
Harsen Laboratories
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Dexchlorpheniramine product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Dexchlorpheniramine, with price, sales, revenue and global market share of Dexchlorpheniramine from 2019 to 2022.
Chapter 3, the Dexchlorpheniramine competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Dexchlorpheniramine breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Dexchlorpheniramine market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Dexchlorpheniramine.
Chapter 13, 14, and 15, to describe Dexchlorpheniramine sales channel, distributors, customers, research findings and conclusion, appendix and data source.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Market Overview
1.1 Dexchlorpheniramine Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Dexchlorpheniramine Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Patent
1.2.3 Generic
1.3 Market Analysis by Application
1.3.1 Overview: Global Dexchlorpheniramine Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Antiallergic Agent
1.3.3 Histamine H₁-Receptor Antagonist
1.4 Global Dexchlorpheniramine Market Size & Forecast
1.4.1 Global Dexchlorpheniramine Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Dexchlorpheniramine Sales in Volume (2017-2028)
1.4.3 Global Dexchlorpheniramine Price (2017-2028)
1.5 Global Dexchlorpheniramine Production Capacity Analysis
1.5.1 Global Dexchlorpheniramine Total Production Capacity (2017-2028)
1.5.2 Global Dexchlorpheniramine Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Dexchlorpheniramine Market Drivers
1.6.2 Dexchlorpheniramine Market Restraints
1.6.3 Dexchlorpheniramine Trends Analysis
2 Manufacturers Profiles
2.1 LETI
2.1.1 LETI Details
2.1.2 LETI Major Business
2.1.3 LETI Dexchlorpheniramine Product and Services
2.1.4 LETI Dexchlorpheniramine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Novartis
2.2.1 Novartis Details
2.2.2 Novartis Major Business
2.2.3 Novartis Dexchlorpheniramine Product and Services
2.2.4 Novartis Dexchlorpheniramine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Hypera Pharma
2.3.1 Hypera Pharma Details
2.3.2 Hypera Pharma Major Business
2.3.3 Hypera Pharma Dexchlorpheniramine Product and Services
2.3.4 Hypera Pharma Dexchlorpheniramine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Woodward
2.4.1 Woodward Details
2.4.2 Woodward Major Business
2.4.3 Woodward Dexchlorpheniramine Product and Services
2.4.4 Woodward Dexchlorpheniramine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Merck
2.5.1 Merck Details
2.5.2 Merck Major Business
2.5.3 Merck Dexchlorpheniramine Product and Services
2.5.4 Merck Dexchlorpheniramine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Johnson and Johnson
2.6.1 Johnson and Johnson Details
2.6.2 Johnson and Johnson Major Business
2.6.3 Johnson and Johnson Dexchlorpheniramine Product and Services
2.6.4 Johnson and Johnson Dexchlorpheniramine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 Ethical Pharma
2.7.1 Ethical Pharma Details
2.7.2 Ethical Pharma Major Business
2.7.3 Ethical Pharma Dexchlorpheniramine Product and Services
2.7.4 Ethical Pharma Dexchlorpheniramine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 Gems Pharma
2.8.1 Gems Pharma Details
2.8.2 Gems Pharma Major Business
2.8.3 Gems Pharma Dexchlorpheniramine Product and Services
2.8.4 Gems Pharma Dexchlorpheniramine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 KPL Pharma
2.9.1 KPL Pharma Details
2.9.2 KPL Pharma Major Business
2.9.3 KPL Pharma Dexchlorpheniramine Product and Services
2.9.4 KPL Pharma Dexchlorpheniramine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10 GlaxoSmithKline
2.10.1 GlaxoSmithKline Details
2.10.2 GlaxoSmithKline Major Business
2.10.3 GlaxoSmithKline Dexchlorpheniramine Product and Services
2.10.4 GlaxoSmithKline Dexchlorpheniramine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11 Ying Yuan
2.11.1 Ying Yuan Details
2.11.2 Ying Yuan Major Business
2.11.3 Ying Yuan Dexchlorpheniramine Product and Services
2.11.4 Ying Yuan Dexchlorpheniramine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.12 Schering-Plough
2.12.1 Schering-Plough Details
2.12.2 Schering-Plough Major Business
2.12.3 Schering-Plough Dexchlorpheniramine Product and Services
2.12.4 Schering-Plough Dexchlorpheniramine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.13 Towa Yakuhin
2.13.1 Towa Yakuhin Details
2.13.2 Towa Yakuhin Major Business
2.13.3 Towa Yakuhin Dexchlorpheniramine Product and Services
2.13.4 Towa Yakuhin Dexchlorpheniramine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.14 Mantecorp FSA
2.14.1 Mantecorp FSA Details
2.14.2 Mantecorp FSA Major Business
2.14.3 Mantecorp FSA Dexchlorpheniramine Product and Services
2.14.4 Mantecorp FSA Dexchlorpheniramine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.15 Kalbe
2.15.1 Kalbe Details
2.15.2 Kalbe Major Business
2.15.3 Kalbe Dexchlorpheniramine Product and Services
2.15.4 Kalbe Dexchlorpheniramine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.16 Teva
2.16.1 Teva Details
2.16.2 Teva Major Business
2.16.3 Teva Dexchlorpheniramine Product and Services
2.16.4 Teva Dexchlorpheniramine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.17 Bayer
2.17.1 Bayer Details
2.17.2 Bayer Major Business
2.17.3 Bayer Dexchlorpheniramine Product and Services
2.17.4 Bayer Dexchlorpheniramine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.18 Mekophar
2.18.1 Mekophar Details
2.18.2 Mekophar Major Business
2.18.3 Mekophar Dexchlorpheniramine Product and Services
2.18.4 Mekophar Dexchlorpheniramine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.19 CFR Pharmaceuticals
2.19.1 CFR Pharmaceuticals Details
2.19.2 CFR Pharmaceuticals Major Business
2.19.3 CFR Pharmaceuticals Dexchlorpheniramine Product and Services
2.19.4 CFR Pharmaceuticals Dexchlorpheniramine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.20 Armoxindo Farma
2.20.1 Armoxindo Farma Details
2.20.2 Armoxindo Farma Major Business
2.20.3 Armoxindo Farma Dexchlorpheniramine Product and Services
2.20.4 Armoxindo Farma Dexchlorpheniramine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.21 Sawai Seiyaku
2.21.1 Sawai Seiyaku Details
2.21.2 Sawai Seiyaku Major Business
2.21.3 Sawai Seiyaku Dexchlorpheniramine Product and Services
2.21.4 Sawai Seiyaku Dexchlorpheniramine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.22 Pfizer
2.22.1 Pfizer Details
2.22.2 Pfizer Major Business
2.22.3 Pfizer Dexchlorpheniramine Product and Services
2.22.4 Pfizer Dexchlorpheniramine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.23 Instituto Sanitas
2.23.1 Instituto Sanitas Details
2.23.2 Instituto Sanitas Major Business
2.23.3 Instituto Sanitas Dexchlorpheniramine Product and Services
2.23.4 Instituto Sanitas Dexchlorpheniramine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.24 Caillon and Hamonet
2.24.1 Caillon and Hamonet Details
2.24.2 Caillon and Hamonet Major Business
2.24.3 Caillon and Hamonet Dexchlorpheniramine Product and Services
2.24.4 Caillon and Hamonet Dexchlorpheniramine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.25 Kobayashi Kako
2.25.1 Kobayashi Kako Details
2.25.2 Kobayashi Kako Major Business
2.25.3 Kobayashi Kako Dexchlorpheniramine Product and Services
2.25.4 Kobayashi Kako Dexchlorpheniramine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.26 Greater Pharma
2.26.1 Greater Pharma Details
2.26.2 Greater Pharma Major Business
2.26.3 Greater Pharma Dexchlorpheniramine Product and Services
2.26.4 Greater Pharma Dexchlorpheniramine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.27 Teuto Brasileiro
2.27.1 Teuto Brasileiro Details
2.27.2 Teuto Brasileiro Major Business
2.27.3 Teuto Brasileiro Dexchlorpheniramine Product and Services
2.27.4 Teuto Brasileiro Dexchlorpheniramine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.28 Harsen Laboratories
2.28.1 Harsen Laboratories Details
2.28.2 Harsen Laboratories Major Business
2.28.3 Harsen Laboratories Dexchlorpheniramine Product and Services
2.28.4 Harsen Laboratories Dexchlorpheniramine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Dexchlorpheniramine Breakdown Data by Manufacturer
3.1 Global Dexchlorpheniramine Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Dexchlorpheniramine Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Dexchlorpheniramine
3.4 Market Concentration Rate
3.4.1 Top 3 Dexchlorpheniramine Manufacturer Market Share in 2021
3.4.2 Top 6 Dexchlorpheniramine Manufacturer Market Share in 2021
3.5 Global Dexchlorpheniramine Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Dexchlorpheniramine Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Dexchlorpheniramine Market Size by Region
4.1.1 Global Dexchlorpheniramine Sales in Volume by Region (2017-2028)
4.1.2 Global Dexchlorpheniramine Revenue by Region (2017-2028)
4.2 North America Dexchlorpheniramine Revenue (2017-2028)
4.3 Europe Dexchlorpheniramine Revenue (2017-2028)
4.4 Asia-Pacific Dexchlorpheniramine Revenue (2017-2028)
4.5 South America Dexchlorpheniramine Revenue (2017-2028)
4.6 Middle East and Africa Dexchlorpheniramine Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Dexchlorpheniramine Sales in Volume by Type (2017-2028)
5.2 Global Dexchlorpheniramine Revenue by Type (2017-2028)
5.3 Global Dexchlorpheniramine Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Dexchlorpheniramine Sales in Volume by Application (2017-2028)
6.2 Global Dexchlorpheniramine Revenue by Application (2017-2028)
6.3 Global Dexchlorpheniramine Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Dexchlorpheniramine Sales by Type (2017-2028)
7.2 North America Dexchlorpheniramine Sales by Application (2017-2028)
7.3 North America Dexchlorpheniramine Market Size by Country
7.3.1 North America Dexchlorpheniramine Sales in Volume by Country (2017-2028)
7.3.2 North America Dexchlorpheniramine Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Dexchlorpheniramine Sales by Type (2017-2028)
8.2 Europe Dexchlorpheniramine Sales by Application (2017-2028)
8.3 Europe Dexchlorpheniramine Market Size by Country
8.3.1 Europe Dexchlorpheniramine Sales in Volume by Country (2017-2028)
8.3.2 Europe Dexchlorpheniramine Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Dexchlorpheniramine Sales by Type (2017-2028)
9.2 Asia-Pacific Dexchlorpheniramine Sales by Application (2017-2028)
9.3 Asia-Pacific Dexchlorpheniramine Market Size by Region
9.3.1 Asia-Pacific Dexchlorpheniramine Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Dexchlorpheniramine Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Dexchlorpheniramine Sales by Type (2017-2028)
10.2 South America Dexchlorpheniramine Sales by Application (2017-2028)
10.3 South America Dexchlorpheniramine Market Size by Country
10.3.1 South America Dexchlorpheniramine Sales in Volume by Country (2017-2028)
10.3.2 South America Dexchlorpheniramine Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Dexchlorpheniramine Sales by Type (2017-2028)
11.2 Middle East & Africa Dexchlorpheniramine Sales by Application (2017-2028)
11.3 Middle East & Africa Dexchlorpheniramine Market Size by Country
11.3.1 Middle East & Africa Dexchlorpheniramine Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Dexchlorpheniramine Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Dexchlorpheniramine and Key Manufacturers
12.2 Manufacturing Costs Percentage of Dexchlorpheniramine
12.3 Dexchlorpheniramine Production Process
12.4 Dexchlorpheniramine Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Dexchlorpheniramine Typical Distributors
13.3 Dexchlorpheniramine Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer
List of Tables
Table 1. Global Dexchlorpheniramine Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Dexchlorpheniramine Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. LETI Basic Information, Manufacturing Base and Competitors
Table 4. LETI Major Business
Table 5. LETI Dexchlorpheniramine Product and Services
Table 6. LETI Dexchlorpheniramine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. Novartis Basic Information, Manufacturing Base and Competitors
Table 8. Novartis Major Business
Table 9. Novartis Dexchlorpheniramine Product and Services
Table 10. Novartis Dexchlorpheniramine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. Hypera Pharma Basic Information, Manufacturing Base and Competitors
Table 12. Hypera Pharma Major Business
Table 13. Hypera Pharma Dexchlorpheniramine Product and Services
Table 14. Hypera Pharma Dexchlorpheniramine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. Woodward Basic Information, Manufacturing Base and Competitors
Table 16. Woodward Major Business
Table 17. Woodward Dexchlorpheniramine Product and Services
Table 18. Woodward Dexchlorpheniramine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. Merck Basic Information, Manufacturing Base and Competitors
Table 20. Merck Major Business
Table 21. Merck Dexchlorpheniramine Product and Services
Table 22. Merck Dexchlorpheniramine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. Johnson and Johnson Basic Information, Manufacturing Base and Competitors
Table 24. Johnson and Johnson Major Business
Table 25. Johnson and Johnson Dexchlorpheniramine Product and Services
Table 26. Johnson and Johnson Dexchlorpheniramine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 27. Ethical Pharma Basic Information, Manufacturing Base and Competitors
Table 28. Ethical Pharma Major Business
Table 29. Ethical Pharma Dexchlorpheniramine Product and Services
Table 30. Ethical Pharma Dexchlorpheniramine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 31. Gems Pharma Basic Information, Manufacturing Base and Competitors
Table 32. Gems Pharma Major Business
Table 33. Gems Pharma Dexchlorpheniramine Product and Services
Table 34. Gems Pharma Dexchlorpheniramine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 35. KPL Pharma Basic Information, Manufacturing Base and Competitors
Table 36. KPL Pharma Major Business
Table 37. KPL Pharma Dexchlorpheniramine Product and Services
Table 38. KPL Pharma Dexchlorpheniramine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 39. GlaxoSmithKline Basic Information, Manufacturing Base and Competitors
Table 40. GlaxoSmithKline Major Business
Table 41. GlaxoSmithKline Dexchlorpheniramine Product and Services
Table 42. GlaxoSmithKline Dexchlorpheniramine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 43. Ying Yuan Basic Information, Manufacturing Base and Competitors
Table 44. Ying Yuan Major Business
Table 45. Ying Yuan Dexchlorpheniramine Product and Services
Table 46. Ying Yuan Dexchlorpheniramine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 47. Schering-Plough Basic Information, Manufacturing Base and Competitors
Table 48. Schering-Plough Major Business
Table 49. Schering-Plough Dexchlorpheniramine Product and Services
Table 50. Schering-Plough Dexchlorpheniramine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 51. Towa Yakuhin Basic Information, Manufacturing Base and Competitors
Table 52. Towa Yakuhin Major Business
Table 53. Towa Yakuhin Dexchlorpheniramine Product and Services
Table 54. Towa Yakuhin Dexchlorpheniramine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 55. Mantecorp FSA Basic Information, Manufacturing Base and Competitors
Table 56. Mantecorp FSA Major Business
Table 57. Mantecorp FSA Dexchlorpheniramine Product and Services
Table 58. Mantecorp FSA Dexchlorpheniramine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 59. Kalbe Basic Information, Manufacturing Base and Competitors
Table 60. Kalbe Major Business
Table 61. Kalbe Dexchlorpheniramine Product and Services
Table 62. Kalbe Dexchlorpheniramine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 63. Teva Basic Information, Manufacturing Base and Competitors
Table 64. Teva Major Business
Table 65. Teva Dexchlorpheniramine Product and Services
Table 66. Teva Dexchlorpheniramine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 67. Bayer Basic Information, Manufacturing Base and Competitors
Table 68. Bayer Major Business
Table 69. Bayer Dexchlorpheniramine Product and Services
Table 70. Bayer Dexchlorpheniramine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 71. Mekophar Basic Information, Manufacturing Base and Competitors
Table 72. Mekophar Major Business
Table 73. Mekophar Dexchlorpheniramine Product and Services
Table 74. Mekophar Dexchlorpheniramine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 75. CFR Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 76. CFR Pharmaceuticals Major Business
Table 77. CFR Pharmaceuticals Dexchlorpheniramine Product and Services
Table 78. CFR Pharmaceuticals Dexchlorpheniramine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 79. Armoxindo Farma Basic Information, Manufacturing Base and Competitors
Table 80. Armoxindo Farma Major Business
Table 81. Armoxindo Farma Dexchlorpheniramine Product and Services
Table 82. Armoxindo Farma Dexchlorpheniramine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 83. Sawai Seiyaku Basic Information, Manufacturing Base and Competitors
Table 84. Sawai Seiyaku Major Business
Table 85. Sawai Seiyaku Dexchlorpheniramine Product and Services
Table 86. Sawai Seiyaku Dexchlorpheniramine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 87. Pfizer Basic Information, Manufacturing Base and Competitors
Table 88. Pfizer Major Business
Table 89. Pfizer Dexchlorpheniramine Product and Services
Table 90. Pfizer Dexchlorpheniramine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 91. Instituto Sanitas Basic Information, Manufacturing Base and Competitors
Table 92. Instituto Sanitas Major Business
Table 93. Instituto Sanitas Dexchlorpheniramine Product and Services
Table 94. Instituto Sanitas Dexchlorpheniramine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 95. Caillon and Hamonet Basic Information, Manufacturing Base and Competitors
Table 96. Caillon and Hamonet Major Business
Table 97. Caillon and Hamonet Dexchlorpheniramine Product and Services
Table 98. Caillon and Hamonet Dexchlorpheniramine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 99. Kobayashi Kako Basic Information, Manufacturing Base and Competitors
Table 100. Kobayashi Kako Major Business
Table 101. Kobayashi Kako Dexchlorpheniramine Product and Services
Table 102. Kobayashi Kako Dexchlorpheniramine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 103. Greater Pharma Basic Information, Manufacturing Base and Competitors
Table 104. Greater Pharma Major Business
Table 105. Greater Pharma Dexchlorpheniramine Product and Services
Table 106. Greater Pharma Dexchlorpheniramine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 107. Teuto Brasileiro Basic Information, Manufacturing Base and Competitors
Table 108. Teuto Brasileiro Major Business
Table 109. Teuto Brasileiro Dexchlorpheniramine Product and Services
Table 110. Teuto Brasileiro Dexchlorpheniramine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 111. Harsen Laboratories Basic Information, Manufacturing Base and Competitors
Table 112. Harsen Laboratories Major Business
Table 113. Harsen Laboratories Dexchlorpheniramine Product and Services
Table 114. Harsen Laboratories Dexchlorpheniramine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 115. Global Dexchlorpheniramine Sales by Manufacturer (2019, 2020, 2021, and 2022) & (K Units)
Table 116. Global Dexchlorpheniramine Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 117. Market Position of Manufacturers in Dexchlorpheniramine, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 118. Global Dexchlorpheniramine Production Capacity by Company, (K Units): 2020 VS 2021
Table 119. Head Office and Dexchlorpheniramine Production Site of Key Manufacturer
Table 120. Dexchlorpheniramine New Entrant and Capacity Expansion Plans
Table 121. Dexchlorpheniramine Mergers & Acquisitions in the Past Five Years
Table 122. Global Dexchlorpheniramine Sales by Region (2017-2022) & (K Units)
Table 123. Global Dexchlorpheniramine Sales by Region (2023-2028) & (K Units)
Table 124. Global Dexchlorpheniramine Revenue by Region (2017-2022) & (USD Million)
Table 125. Global Dexchlorpheniramine Revenue by Region (2023-2028) & (USD Million)
Table 126. Global Dexchlorpheniramine Sales by Type (2017-2022) & (K Units)
Table 127. Global Dexchlorpheniramine Sales by Type (2023-2028) & (K Units)
Table 128. Global Dexchlorpheniramine Revenue by Type (2017-2022) & (USD Million)
Table 129. Global Dexchlorpheniramine Revenue by Type (2023-2028) & (USD Million)
Table 130. Global Dexchlorpheniramine Price by Type (2017-2022) & (US$/Unit)
Table 131. Global Dexchlorpheniramine Price by Type (2023-2028) & (US$/Unit)
Table 132. Global Dexchlorpheniramine Sales by Application (2017-2022) & (K Units)
Table 133. Global Dexchlorpheniramine Sales by Application (2023-2028) & (K Units)
Table 134. Global Dexchlorpheniramine Revenue by Application (2017-2022) & (USD Million)
Table 135. Global Dexchlorpheniramine Revenue by Application (2023-2028) & (USD Million)
Table 136. Global Dexchlorpheniramine Price by Application (2017-2022) & (US$/Unit)
Table 137. Global Dexchlorpheniramine Price by Application (2023-2028) & (US$/Unit)
Table 138. North America Dexchlorpheniramine Sales by Country (2017-2022) & (K Units)
Table 139. North America Dexchlorpheniramine Sales by Country (2023-2028) & (K Units)
Table 140. North America Dexchlorpheniramine Revenue by Country (2017-2022) & (USD Million)
Table 141. North America Dexchlorpheniramine Revenue by Country (2023-2028) & (USD Million)
Table 142. North America Dexchlorpheniramine Sales by Type (2017-2022) & (K Units)
Table 143. North America Dexchlorpheniramine Sales by Type (2023-2028) & (K Units)
Table 144. North America Dexchlorpheniramine Sales by Application (2017-2022) & (K Units)
Table 145. North America Dexchlorpheniramine Sales by Application (2023-2028) & (K Units)
Table 146. Europe Dexchlorpheniramine Sales by Country (2017-2022) & (K Units)
Table 147. Europe Dexchlorpheniramine Sales by Country (2023-2028) & (K Units)
Table 148. Europe Dexchlorpheniramine Revenue by Country (2017-2022) & (USD Million)
Table 149. Europe Dexchlorpheniramine Revenue by Country (2023-2028) & (USD Million)
Table 150. Europe Dexchlorpheniramine Sales by Type (2017-2022) & (K Units)
Table 151. Europe Dexchlorpheniramine Sales by Type (2023-2028) & (K Units)
Table 152. Europe Dexchlorpheniramine Sales by Application (2017-2022) & (K Units)
Table 153. Europe Dexchlorpheniramine Sales by Application (2023-2028) & (K Units)
Table 154. Asia-Pacific Dexchlorpheniramine Sales by Region (2017-2022) & (K Units)
Table 155. Asia-Pacific Dexchlorpheniramine Sales by Region (2023-2028) & (K Units)
Table 156. Asia-Pacific Dexchlorpheniramine Revenue by Region (2017-2022) & (USD Million)
Table 157. Asia-Pacific Dexchlorpheniramine Revenue by Region (2023-2028) & (USD Million)
Table 158. Asia-Pacific Dexchlorpheniramine Sales by Type (2017-2022) & (K Units)
Table 159. Asia-Pacific Dexchlorpheniramine Sales by Type (2023-2028) & (K Units)
Table 160. Asia-Pacific Dexchlorpheniramine Sales by Application (2017-2022) & (K Units)
Table 161. Asia-Pacific Dexchlorpheniramine Sales by Application (2023-2028) & (K Units)
Table 162. South America Dexchlorpheniramine Sales by Country (2017-2022) & (K Units)
Table 163. South America Dexchlorpheniramine Sales by Country (2023-2028) & (K Units)
Table 164. South America Dexchlorpheniramine Revenue by Country (2017-2022) & (USD Million)
Table 165. South America Dexchlorpheniramine Revenue by Country (2023-2028) & (USD Million)
Table 166. South America Dexchlorpheniramine Sales by Type (2017-2022) & (K Units)
Table 167. South America Dexchlorpheniramine Sales by Type (2023-2028) & (K Units)
Table 168. South America Dexchlorpheniramine Sales by Application (2017-2022) & (K Units)
Table 169. South America Dexchlorpheniramine Sales by Application (2023-2028) & (K Units)
Table 170. Middle East & Africa Dexchlorpheniramine Sales by Region (2017-2022) & (K Units)
Table 171. Middle East & Africa Dexchlorpheniramine Sales by Region (2023-2028) & (K Units)
Table 172. Middle East & Africa Dexchlorpheniramine Revenue by Region (2017-2022) & (USD Million)
Table 173. Middle East & Africa Dexchlorpheniramine Revenue by Region (2023-2028) & (USD Million)
Table 174. Middle East & Africa Dexchlorpheniramine Sales by Type (2017-2022) & (K Units)
Table 175. Middle East & Africa Dexchlorpheniramine Sales by Type (2023-2028) & (K Units)
Table 176. Middle East & Africa Dexchlorpheniramine Sales by Application (2017-2022) & (K Units)
Table 177. Middle East & Africa Dexchlorpheniramine Sales by Application (2023-2028) & (K Units)
Table 178. Dexchlorpheniramine Raw Material
Table 179. Key Manufacturers of Dexchlorpheniramine Raw Materials
Table 180. Direct Channel Pros & Cons
Table 181. Indirect Channel Pros & Cons
Table 182. Dexchlorpheniramine Typical Distributors
Table 183. Dexchlorpheniramine Typical Customers
List of Figures
Figure 1. Dexchlorpheniramine Picture
Figure 2. Global Dexchlorpheniramine Revenue Market Share by Type in 2021
Figure 3. Patent
Figure 4. Generic
Figure 5. Global Dexchlorpheniramine Revenue Market Share by Application in 2021
Figure 6. Antiallergic Agent
Figure 7. Histamine H₁-Receptor Antagonist
Figure 8. Global Dexchlorpheniramine Revenue, (USD Million) & (K Units): 2017 & 2021 & 2028
Figure 9. Global Dexchlorpheniramine Revenue and Forecast (2017-2028) & (USD Million)
Figure 10. Global Dexchlorpheniramine Sales (2017-2028) & (K Units)
Figure 11. Global Dexchlorpheniramine Price (2017-2028) & (US$/Unit)
Figure 12. Global Dexchlorpheniramine Production Capacity (2017-2028) & (K Units)
Figure 13. Global Dexchlorpheniramine Production Capacity by Geographic Region: 2022 VS 2028
Figure 14. Dexchlorpheniramine Market Drivers
Figure 15. Dexchlorpheniramine Market Restraints
Figure 16. Dexchlorpheniramine Market Trends
Figure 17. Global Dexchlorpheniramine Sales Market Share by Manufacturer in 2021
Figure 18. Global Dexchlorpheniramine Revenue Market Share by Manufacturer in 2021
Figure 19. Dexchlorpheniramine Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 20. Top 3 Dexchlorpheniramine Manufacturer (Revenue) Market Share in 2021
Figure 21. Top 6 Dexchlorpheniramine Manufacturer (Revenue) Market Share in 2021
Figure 22. Global Dexchlorpheniramine Sales Market Share by Region (2017-2028)
Figure 23. Global Dexchlorpheniramine Revenue Market Share by Region (2017-2028)
Figure 24. North America Dexchlorpheniramine Revenue (2017-2028) & (USD Million)
Figure 25. Europe Dexchlorpheniramine Revenue (2017-2028) & (USD Million)
Figure 26. Asia-Pacific Dexchlorpheniramine Revenue (2017-2028) & (USD Million)
Figure 27. South America Dexchlorpheniramine Revenue (2017-2028) & (USD Million)
Figure 28. Middle East & Africa Dexchlorpheniramine Revenue (2017-2028) & (USD Million)
Figure 29. Global Dexchlorpheniramine Sales Market Share by Type (2017-2028)
Figure 30. Global Dexchlorpheniramine Revenue Market Share by Type (2017-2028)
Figure 31. Global Dexchlorpheniramine Price by Type (2017-2028) & (US$/Unit)
Figure 32. Global Dexchlorpheniramine Sales Market Share by Application (2017-2028)
Figure 33. Global Dexchlorpheniramine Revenue Market Share by Application (2017-2028)
Figure 34. Global Dexchlorpheniramine Price by Application (2017-2028) & (US$/Unit)
Figure 35. North America Dexchlorpheniramine Sales Market Share by Type (2017-2028)
Figure 36. North America Dexchlorpheniramine Sales Market Share by Application (2017-2028)
Figure 37. North America Dexchlorpheniramine Sales Market Share by Country (2017-2028)
Figure 38. North America Dexchlorpheniramine Revenue Market Share by Country (2017-2028)
Figure 39. United States Dexchlorpheniramine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 40. Canada Dexchlorpheniramine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 41. Mexico Dexchlorpheniramine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 42. Europe Dexchlorpheniramine Sales Market Share by Type (2017-2028)
Figure 43. Europe Dexchlorpheniramine Sales Market Share by Application (2017-2028)
Figure 44. Europe Dexchlorpheniramine Sales Market Share by Country (2017-2028)
Figure 45. Europe Dexchlorpheniramine Revenue Market Share by Country (2017-2028)
Figure 46. Germany Dexchlorpheniramine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 47. France Dexchlorpheniramine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 48. United Kingdom Dexchlorpheniramine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 49. Russia Dexchlorpheniramine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. Italy Dexchlorpheniramine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. Asia-Pacific Dexchlorpheniramine Sales Market Share by Region (2017-2028)
Figure 52. Asia-Pacific Dexchlorpheniramine Sales Market Share by Application (2017-2028)
Figure 53. Asia-Pacific Dexchlorpheniramine Sales Market Share by Region (2017-2028)
Figure 54. Asia-Pacific Dexchlorpheniramine Revenue Market Share by Region (2017-2028)
Figure 55. China Dexchlorpheniramine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 56. Japan Dexchlorpheniramine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 57. Korea Dexchlorpheniramine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. India Dexchlorpheniramine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. Southeast Asia Dexchlorpheniramine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. Australia Dexchlorpheniramine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. South America Dexchlorpheniramine Sales Market Share by Type (2017-2028)
Figure 62. South America Dexchlorpheniramine Sales Market Share by Application (2017-2028)
Figure 63. South America Dexchlorpheniramine Sales Market Share by Country (2017-2028)
Figure 64. South America Dexchlorpheniramine Revenue Market Share by Country (2017-2028)
Figure 65. Brazil Dexchlorpheniramine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 66. Argentina Dexchlorpheniramine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 67. Middle East & Africa Dexchlorpheniramine Sales Market Share by Type (2017-2028)
Figure 68. Middle East & Africa Dexchlorpheniramine Sales Market Share by Application (2017-2028)
Figure 69. Middle East & Africa Dexchlorpheniramine Sales Market Share by Region (2017-2028)
Figure 70. Middle East & Africa Dexchlorpheniramine Revenue Market Share by Region (2017-2028)
Figure 71. Turkey Dexchlorpheniramine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 72. Egypt Dexchlorpheniramine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 73. Saudi Arabia Dexchlorpheniramine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 74. South Africa Dexchlorpheniramine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. Manufacturing Cost Structure Analysis of Dexchlorpheniramine in 2021
Figure 76. Manufacturing Process Analysis of Dexchlorpheniramine
Figure 77. Dexchlorpheniramine Industrial Chain
Figure 78. Sales Channel: Direct Channel vs Indirect Channel
Figure 79. Methodology
Figure 80. Research Process and Data Source
Please feel free to write an email to us or to use our electronic ticketing system.
